Target Price | GBP16.51 |
Price | GBP15.13 |
Potential |
9.12%
register free of charge
|
Number of Estimates | 18 |
18 Analysts have issued a price target GlaxoSmithKline 2026 .
The average GlaxoSmithKline target price is GBP16.51.
This is
9.12%
register free of charge
GBP26.30
73.83%
register free of charge
GBP11.70
22.67%
register free of charge
|
|
A rating was issued by 23 analysts: 5 Analysts recommend GlaxoSmithKline to buy, 14 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the GlaxoSmithKline stock has an average upside potential 2026 of
9.12%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion GBP | 31.38 | 32.35 |
3.46% | 3.12% | |
EBITDA Margin | 26.11% | 34.07% |
5.46% | 30.49% | |
Net Margin | 8.21% | 18.46% |
49.49% | 124.93% |
19 Analysts have issued a sales forecast GlaxoSmithKline 2025 . The average GlaxoSmithKline sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an GlaxoSmithKline EBITDA forecast 2025. The average GlaxoSmithKline EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 GlaxoSmithKline Analysts have issued a net profit forecast 2025. The average GlaxoSmithKline net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share GBP | 0.62 | 1.44 |
48.33% | 132.26% | |
P/E | 10.49 | |
EV/Sales | 2.30 |
10 Analysts have issued a GlaxoSmithKline forecast for earnings per share. The average GlaxoSmithKline EPS is
This results in the following potential growth metrics and future valuations:
GlaxoSmithKline...
Analyst | Rating | Action | Date |
---|---|---|---|
Shore Capital |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
JP Morgan Cazenove |
Locked
➜
Locked
|
Locked | Mar 28 2025 |
JP Morgan Cazenove |
Locked
➜
Locked
|
Locked | Jan 07 2025 |
JP Morgan Cazenove |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
Berenberg Bank |
Locked
➜
Locked
|
Locked | Nov 29 2024 |
Berenberg Bank |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
Deutsche |
Locked
➜
Locked
|
Locked | Sep 03 2024 |
Analyst Rating | Date |
---|---|
Locked
Shore Capital:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
JP Morgan Cazenove:
Locked
➜
Locked
|
Mar 28 2025 |
Locked
JP Morgan Cazenove:
Locked
➜
Locked
|
Jan 07 2025 |
Locked
JP Morgan Cazenove:
Locked
➜
Locked
|
Dec 11 2024 |
Locked
Berenberg Bank:
Locked
➜
Locked
|
Nov 29 2024 |
Locked
Berenberg Bank:
Locked
➜
Locked
|
Sep 10 2024 |
Locked
Deutsche:
Locked
➜
Locked
|
Sep 03 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.